DDIAgents : Mechanism-Conditioned Context Flow for Drug-Drug Interaction Prediction DOI: XXXXXXX.XXXXXXX ISBN: 978-1-4503-XXXX-X/2018/06

Zhenqian Shen, Yu Liu, Xiaoyi Fu, Quanming Yao · 2026

Read DDIAgents : Mechanism-Conditioned Context Flow for Drug-Drug Interaction Prediction DOI: XXXXXXX.XXXXXXX ISBN: 978-1-4503-XXXX-X/2018/06 by Zhenqian Shen, Yu Liu, Xiaoyi Fu, Quanming Yao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2606-31085.txt.

Introduction

Shen and three colleagues build DDIAgents, a system that predicts drug-drug interactions. Two drugs taken together can change each other's effect, sometimes dangerously. Predicting such interactions means weighing mixed biomedical evidence. Which evidence matters depends on the interaction mechanism at play, and that changes from one drug pair to the next.

DDIAgents uses a team of software agents. A planner agent first infers the likely mechanism for a drug pair. It then creates specialized expert agents and routes the relevant knowledge sources to each one. A conclusion agent merges their analyses into one prediction. The setup cuts irrelevant information and leaves agent-level reasons that a human can inspect. On realistic benchmarks, the system beat feature-based, graph-based, language-model, and other agent-based methods.

Catalog record

CREATORZhenqian Shen, Yu Liu, Xiaoyi Fu, Quanming Yao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE86 KB
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2606.31085

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

DDIAgents : Mechanism-Conditioned Context Flow for Drug-Drug Interaction Prediction DOI: XXXXXXX.XXXXXXX ISBN: 978-1-4503-XXXX-X/2018/06 Zhenqian Shen, Yu Liu, Xiaoyi Fu, Quanming Yao Abstract . Drug-drug interaction (DDI) prediction is essential for medication safety, yet it requires reasoning over heterogeneous biomedical evidence whose relevance changes across interaction mechanisms. We propose DDIAgents, a mechanism-conditioned multi-agent framework that performs DDI prediction through dynamic knowledge orchestration. Given a drug pair, a planner agent instantiates specialized expert agents, routes mechanism-relevant knowledge sources to each agent, and aggregates their analyses through a conclusion agent. By adapting context flow to the inferred interaction mechanism, DDIAgents reduces irrelevant information, supports complementary expert reasoning, and produces interpretable agent-level rationales. Extensive experiments on realistic DDI prediction benchmarks show that DDIAgents consistently outperforms existing feature-based, graph-based, LLM-based, and agent-based baselines. Beyond prediction performance, DDIAgents demonstrates how multi-agent systems can organize heterogeneous scientific knowledge for adaptive and interpretable AI4Science reasoning. 1. Introduction Modern drug discovery is defined by prohibitive costs and protracted timelines, frequently taking 10–15 years and over 2 billion dollars per approved drug ( DiMasi et al. 2016 ; Prasad et al. 2017 ) . It is therefore crucial to identify drug-drug interactions (DDIs) that could lead to adverse drug reactions and serious health risks for patients. However, DDI prediction remains a challenging scientific problem due to intricate biomedical mechanisms, including altered pharmacokinetics and pharmacodynamics ( Palleria et al. 2013 ) , alongside clinical treatment factors ( Roberts and Gibbs 2018 ) . Moreover, candidate DDI verification is expensive and time-consuming, requiring extensive experiments from preclinical studies to large-scale clinical trials. This setting reflects a broader data-efficient AI4Science challenge: direct labels and experimental feedback are costly, so models must make better use of prior knowledge, task structure, and limited feedback rather than relying only on scaling supervision ( Wang et al. 2020 ; Wang et al. 2026 ) . In this work, we focus on a complementary agentic question: how should a reasoning system decide which biomedical evidence each expert should use when the underlying interaction mechanism changes across drug pairs? To accelerate DDI discovery, a variety of computational methods have been developed for prediction ( Qiu et al. 2021 ; Lin et al. 2023 ) . These methods broadly fall into three categories: feature-based, graph-based, and large language model (LLM)-based approaches. Feature-based methods ( Ryu et al. 2018 ; Liu et al. 2022 ) typically encode drugs with molecular features and train neural networks for interaction prediction. Graph-based methods broadly utilize graph embedding methods, graph neural networks (GNNs) or graph transformers to extract predictive features from diverse data sources, ranging from individual drug molecular structures ( Nyamabo et al. 2021 ; Yang et al. 2022 ) to complex biomedical networks ( Zitnik et al. 2018 ; Zhang et al. 2023 ) . LLM-based methods primarily utilize the powerful reasoning capabilities based on textual descriptions of drugs and interactions ( Zhu et al. 2023 ; Xu et al. 2024 ) . Despite these advances, DDI prediction is not merely a single-pattern learning problem; it is a mechanism-conditioned knowledge orchestration problem. First, different drug pairs can be governed by diverse mechanisms , from physiological modulation and drug–target binding events to chemically mediated reactions. Second, the decisive evidence exhibits knowledge heterogeneity , spanning natural-language descriptions, structured biomedical relations, and molecular substructures. A metabolism-driven interaction may require enzyme or transporter evidence, whereas a target-overlap interaction may depend more on pathway or adverse-effect evidence. However, most existing approaches remain inflexible: they follow fixed reasoning patterns and rely on static evidence integration, which can introduce irrelevant evidence or miss the modality that is decisive for a specific mechanism. Meanwhile, the recent emergence of LLM-based multi-agent systems in other scientific domains has become a promising solution for providing adaptable mechanism analysis of DDIs. Analogous to a multidisciplinary research team, multi-agent frameworks coordinate multiple role-specialized “expert” agents to solve complex problems ( Boiko et al. 2023 ; Swanson et al. 2025 ) . This perspective also aligns with data-efficient agentic learning, where performance is improved by organizing roles, feedback, and interactions rather than simply increasing labeled data or model scale ( Wang et al. 2026 ) . In such systems, the reasoning performance critically depends on the context flow , namely how knowledge sources are routed to the agents that need it. However, existing multi-agent systems often rely on a fixed context flow, where agents are restricted to a predefined knowledge scope. This rigidity forces expert agents to handle a fixed scope of knowledge regardless of the specific task, which can introduce irrelevant information into the reasoning process and obscure the critical insights. To address the challenges above, we introduce DDIAgents, a mechanism-conditioned multi-agent framework for DDI prediction that leverages dynamic context flow for specialized DDI analysis. Specifically, DDIAgents conducts the following three stages iteratively. Firstly, expert agent instantiation gathers a team of specialized expert agents. Secondly, dynamic context flow routes suitable knowledge sources to each expert agent according to the mechanism-specific evidence needs of the current drug pair. Finally, expert agents generate domain-specific analyses that are synthesized by a conclusion agent to either yield a final prediction or provide strategic guidance for iterative refinement. Experiments on two benchmark datasets demonstrate the superior performance of DDIAgents compared to existing methods. Furthermore, the agent-based analysis demonstrates that DDIAgents yields interpretable mechanistic explanations of predicted DDIs. The main contributions are summarized as follows: • We formulate DDI prediction as a mechanism-conditioned knowledge orchestration problem and introduce DDIAgents, a multi-agent framework that explicitly accounts for diverse mechanisms and heterogeneous biomedical evidence. • We design a dynamic context flow mechanism that strategically routes heterogeneous knowledge sources to specialized agents, thereby enhancing knowledge utility and reducing noisy information in the DDI reasoning process. • We perform extensive experiments on two benchmark datasets, demonstrating that DDIAgents consistently outperforms existing feature-based, graph-based, LLM-based, and agent-based approaches. Comprehensive case studies further show that DDIAgents provides interpretable agent-level insights into the underlying mechanisms of DDIs. 2. Related Works 2.1. Drug-Drug Interaction Prediction DDI prediction has recently been a critical topic in computational pharmacology, aiming to identify potential drug interactions that may lead to adverse effects or altered therapeutic efficacy ( Han et al. 2022 ; Lin et al. 2023 ) . Existing approaches are commonly grouped into feature-based, graph-based, and LLM-based methods. Feature-based methods encode drugs with molecular descriptors and train supervised predictors ( Rogers and Hahn 2010 ; Ryu et al. 2018 ; Liu et al. 2022 ; Xie et al. 2025 ) . They work well when interactions are driven by chemical properties, but often struggle to incorporate broader biological mechanisms. Graph-based methods exploit structured relations from molecular graphs and biomedical networks through knowledge graph embedding methods ( Yao et al. 2022 ) , GNNs ( Zitnik et al. 2018 ; Zhang et al. 2023 ) or heterogeneous graph transformers ( Su et al. 2024 ) . While they better capture relational evidence, their pipelines and knowledge fusion are typically fixed, limiting adaptability when the decisive evidence varies across drug pairs. Recently, LLM-based methods prompt models with drug or interaction descriptions ( Zhu et al. 2023 ; Xu et al. 2024 ; Raveendran et al. 2025 ) , retrieve graph-path evidence ( Abdullahi et al.

Read the complete text